Skip to main content
. 2020 Feb 26;15(2):e0229577. doi: 10.1371/journal.pone.0229577

Fig 4. Re-evaluated prognosis prediction model for cancer immunity-related miRNAs in PCNSL.

Fig 4

(A) Representative miRNAs encompassing cancer immunity in the training data set (n = 20). (B) Remodeling of the prognosis prediction for cancer immunity-related miRNAs with clinical information including age, gender, KPS, serum LDH level, and deep-seated lesion in the total data set (n = 39, one sample deleted due to a missing value of LDH). Kaplan-Meier analyses cut off by the median score calculated by the prognosis formula based on the Cox regression analysis. OS; overall survival, HR; hazard ratio.